TrialClinical pharmacokinetics2024

Safety and Pharmacokinetics of HRS-2261, a P2X3 Receptor Antagonist, in Healthy Subjects: A Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Yuru Fan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.